The utility of breast MRI as a problem-solving tool

Breast Journal

Volumn 17, Issue 3, 2011, Pages 273-280

  Yau, Edwin J ^a   Gutierrez, Robert L ^a,c   Demartini, Wendy B ^a   Eby, Peter R ^a   Peacock, Sue ^b   Lehman, Constance D ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b SEATTLE CANCER CARE ALLIANCE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

breast; equivocal; inconclusive; MRI; problem solving; utility

Indexed keywords

GADODIAMIDE;

ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROBLEM SOLVING; RISK BENEFIT ANALYSIS; ULTRASOUND;

BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBLEM SOLVING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 79955690959     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2011.01075.x     Document Type: Article

References (43)

1. DeMartini W, Lehman C,. A review of current evidence-based clinical applications for breast magnetic resonance imaging. Top Magn Reson Imaging 2008; 19: 143-50.
2. DeMartini W, Lehman C, Partridge S,. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. Acad Radiol 2008; 15: 408-16. (Pubitemid 351384707)
3. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351: 427-37.
4. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005; 23: 8469-76.
5. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005; 365: 1769-78. (Pubitemid 40744657)
6. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005; 103: 1898-905. (Pubitemid 40563263)
7. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007; 244: 381-8. (Pubitemid 47080869)
8. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003; 181: 619-26. (Pubitemid 37021827)
9. Plevritis SK, Kurian AW, Sigal BM, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 2006; 295: 2374-84. (Pubitemid 43788105)
10. Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002; 21 (Suppl 3): 115-24. (Pubitemid 36114245)
11. Sardanelli F, Podo F, D'Agnolo G, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007; 242: 698-715.
12. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57: 75-89. (Pubitemid 46535708)
13. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M,. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000; 63: 53-60.
14. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292: 1317-25. (Pubitemid 39223222)
15. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003; 98: 468-73. (Pubitemid 36885985)
16. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004; 233: 830-49.
17. Fischer U, Kopka L, Grabbe E,. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999; 213: 881-8.
18. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187: 493-501. (Pubitemid 23127861)
19. Hollingsworth AB, Stough RG, O'Dell CA, Brekke CE,. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg 2008; 196: 389-97.
20. Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 2005; 92: 9-15; discussion 15-6. (Pubitemid 41416422)
21. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356: 1295-303. (Pubitemid 46513295)
22. Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK,. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 2003; 180: 901-10. (Pubitemid 36363023)
23. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 1997; 169: 417-24. (Pubitemid 27334851)
24. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196: 115-22.
25. Schelfout K, Van Goethem M, Kersschot E, et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 2004; 30: 501-7. (Pubitemid 38701871)
26. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ,. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 2002; 20: 3413-23.
27. ACR. ACR BI-RADSA- MRI. ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas. Reston, VA: American College of Radiology, 2003.
28. Lee CH,. Problem solving MR imaging of the breast. Radiol Clin North Am 2004; 42: 919-34. (Pubitemid 39165072)
29. Lee CH, Smith RC, Levine JA, Troiano RN, Tocino I,. Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram. AJR Am J Roentgenol 1999; 173: 1323-9. (Pubitemid 29494015)
30. Moy L, Elias K, Patel V, et al. Is breast MRI helpful in the evaluation of inconclusive mammographic findings? AJR Am J Roentgenol 2009; 193: 986-93.
31. Sardanelli F, Melani E, Ottonello C, et al. Magnetic resonance imaging of the breast in characterizing positive or uncertain mammographic findings. Cancer Detect Prev 1998; 22: 39-42. (Pubitemid 28073339)
32. Gray RJ, Pockaj BA, Karstaedt PJ,. Navigating murky waters: a modern treatment algorithm for nipple discharge. Am J Surg 2007; 194: 850-4; discussion 54-5.
33. Mortellaro VE, Marshall J, Harms SE, Hochwald SN, Copeland EM 3rd, Grobmyer SR,. Breast MR for the evaluation of occult nipple discharge. Am Surg 2008; 74: 739-42.
34. Vargas HI, Vargas MP, Eldrageely K, Gonzalez KD, Khalkhali I,. Outcomes of clinical and surgical assessment of women with pathological nipple discharge. Am Surg 2006; 72: 124-8. (Pubitemid 46940753)
35. ACR American College of Radiology (ACR) Appropriateness Criteria. Available at http://www.acr.org, 2010.
36. Carlson RWAD, Anderson BO, et al. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer version 1, 2009. Available at. www.nccn.com.
37. Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 2005; 92: 32-8. (Pubitemid 41416426)
38. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004; 292: 2735-42. (Pubitemid 39628252)
39. Cilotti A, Iacconi C, Marini C, et al. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications. Radiol Med 2007; 112: 272-86. (Pubitemid 46474832)
40. Akita A, Tanimoto A, Jinno H, Kameyama K, Kuribayashi S,. The clinical value of bilateral breast MR imaging: is it worth performing on patients showing suspicious microcalcifications on mammography? Eur Radiol 2009; 19: 2089-96.
41. Griebsch I, Brown J, Boggis C, et al. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer 2006; 95: 801-10. (Pubitemid 44498093)
42. Moore SG, Shenoy PJ, Fanucchi L, Tumeh JW, Flowers CR,. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res 2009; 9:9.
43. Taneja C, Edelsberg J, Weycker D, Guo A, Oster G, Weinreb J,. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol 2009; 6: 171-9.